T2000

DRUG3 trials

Sponsors

Sun Pharmaceutical Industries, Inc.

Conditions

Essential TremorMyoclonus

Phase 2

A Study of T2000 in Essential Tremor

TerminatedNCT00321087

Sun Pharmaceutical Industries, Inc.Essential Tremor

Start: 2006-08-31End: 2007-12-31Updated: 2014-01-22

Pilot Efficacy Study of T2000 in Myoclonus Dystonia

TerminatedNCT00506012

Sun Pharmaceutical Industries, Inc.Myoclonus

Start: 2007-08-31End: 2011-10-31Target: 5Updated: 2013-12-23

T2000 in Essential Tremor - Open Label Continuation

TerminatedNCT00655278

Sun Pharmaceutical Industries, Inc.Essential Tremor

Start: 2007-08-31End: 2009-12-31Updated: 2013-12-23